Business Wire

BearingPoint client success story: JobRad Leasing ensures sustainable business growth through a successful financing transaction

Share

BearingPoint assisted JobRad Leasing GmbH in leveraging the Securitization as a Service solution to enhance its data management and reporting capabilities

As society increasingly values sustainability, bicycle mobility is becoming a popular choice for commuting. Another driver of this development is company bike leasing, invented by the Freiburg-based company JobRad. Similar to company car leasing, company bike leasing offers tax advantages that allow employees to save up to 40 percent in cash compared to buying a new bike. With its concept, the industry leader JobRad has so far brought more than 1.5 million people onto bikes. JobRad's central leasing company is the in-house JobRad Leasing GmbH. For refinancing strategies, the company has also been relying on asset-based refinancing for some time.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241211468345/en/

BearingPoint assisted JobRad Leasing GmbH in leveraging the Securitization as a Service solution to enhance its data management and reporting capabilities. (Graphic: Business Wire)

Securitization is key to this type of liquidity management, as it involves pooling financial assets such as loans, leases, or trade receivables and transforming them into a new financial investment product, known as asset-backed commercial paper (ABCP). However, creating a portfolio of eligible assets for ABCP involves managing extensive data from various sources, meeting reporting requirements, and adhering to eligibility criteria. As a result, for its first securitization transaction, the company sought to automate and efficiently develop the asset portfolio while maintaining the feasibility and high level of digitization that characterizes the entire JobRad Group.

Developing bespoke solutions for effective management of securitization transactions

Leveraging its Securitization as a Service solution,BearingPoint assisted JobRad Leasing GmbH in its first securitization transaction. The joint team conducted an interface workshop to identify the data requirements needed to meet market transparency standards. This laid the foundation for comprehensive documentation to pinpoint and evaluate the financial assets to be securitized. In the next step, relevant business logic was defined. Thereafter, BearingPoint configured the technical platform to incorporate JobRad Leasing’s data, business events, and the required types of reporting formats. During the development and testing phase, BearingPoint focused on aligning the reporting capabilities, while ensuring the accuracy and completeness of the data.

Detailed templates were then created for both the functionality and design of all corporate reports related to funding operations, ensuring that compliance standards were met, including reporting, documentation, and disclosure requirements. The project team integrated the securitization platform with the client's existing systems and workflows to enable a smooth transition and maximize operational efficiency. On an ongoing basis, BearingPoint will provide monthly reports throughout the transaction, using data from JobRad Leasing GmbH via the new interface to enable optimal and timely execution of the securitization transaction.

“Data is essential for JobRad to finance its sustainable solutions for eco-mobility in an efficient manner, particularly when it comes to securitization. We are very pleased that BearingPoint’s Securitization as a Service solution enables JobRad to meet the challenging capital market requirements for data quality and data transparency as it contributes to a stable funding, improved liquidity and efficient risk management,” said Donald Wachs, global Leader BearingPoint Products.

Simplifying the complexity of Asset-Based Funding

By using BearingPoint’s Securitization as a Service solution, JobRad Leasing GmbH has enhanced its data management capabilities and can handle effectively the complexities of its first securitization transaction. The highly automated processes have led to substantial improvements in time and resource efficiency. Additionally, the company now benefits from fast access to necessary reports and has shortened the report delivery times.

Moreover, the scalable operations and secure data enable JobRad Leasing GmbH to enhance its liquidity and effectively manage risk. With full visibility into its leasing transaction at all times, the company is able to address compliance and extensive investor transparency requirements, while also meeting the reporting standards set by the European Securities and Markets Authority (ESMA).

“Working with BearingPoint on our first securitization transaction has been a very positive experience for JobRad Leasing GmbH. With BearingPoint's solution, we were able to significantly simplify and streamline our processes and data management to meet our capital markets reporting requirements. As a result, we have been able to further broaden our refinancing base - bringing us one step closer to our goal of putting people on JobRad,” said Benjamin Kräutter, Team Leader Treasury at JobRad.

About JobRad

JobRad Leasing GmbH has been part of the JobRad Group since its market entry in 2019 and, as a bank-independent leasing company, works exclusively with JobRad employers.As one of two possible lessors, JobRad Leasing GmbH is a direct contractual partner of JobRad employers.

About BearingPoint

BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: Consulting, Products, and Capital. Consulting covers the advisory business with a clear focus on selected business areas. Products provides IP-driven digital assets and managed services for business-critical processes. Capital delivers M&A and transaction services.

BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.

BearingPoint is a certified B Corporation, meeting high standards of social and environmental impact.

For more information, please visit:

Homepage: www.bearingpoint.com
Securitization as a Service: www.bearingpoint.services/securitization-as-a-service
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint

View source version on businesswire.com: https://www.businesswire.com/news/home/20241211468345/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 11:07:00 CET | Press release

Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,

ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 10:00:00 CET | Press release

CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including

I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 09:00:00 CET | Press release

Acquisition will accelerate Ramudden’s ambitious growth plan across North America and Europe supported by strong infrastructure spending tailwinds I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that unde

RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 09:00:00 CET | Press release

RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins

Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe7.1.2026 08:30:00 CET | Press release

Exclusive agreement covers 13 Central and Eastern European markets Collaboration will help expand access to VANFLYTA for patients with newly diagnosed FLT3-ITD positive AML Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution and commercialization of VANFLYTA® (quizartinib) in 13 markets across Central and Eastern Europe for the treatment of adult patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML). Under the terms of the agreement, Daiichi Sankyo will be responsible for the manufacturing and supply of VANFLYTA while GENESIS Pharma will lead medical affairs, market access and commercialization efforts in Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. Financial terms of the agreement are not being disclosed. VANFLYTA was approved in the EU in November 2023 for the treatment of adult patients with newly diagnose

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye